Allogene Therapeutics, Inc. (ALLO) Price Prediction & ForecastALLOAllogene Therapeutics, Inc.

Alphio's ALLO stock price prediction model matches the current Allogene Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.25 (+0.19%). The 1-week path is $1.24 (-0.60%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Allogene Therapeutics is not a good buy right now. The current price is $1.25, with an RSI of 23.657 indicating the stock is oversold. The company reported a significant net loss of $42,677,000 in Q2 2026, and its forward P/E ratio is 0, suggesting no expected profitability in the near term. The main risk is the ongoing financial losses, which could hinder future growth and investor confidence.

Allogene Therapeutics, Inc. (ALLO) last closed at $1.25, gaining +0.00%. These facts feed the 1-day and 1-week ALLO price prediction above.